Literature DB >> 21068301

Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output.

Matthew N Hill1, Sachin Patel, Patrizia Campolongo, Jeffrey G Tasker, Carsten T Wotjak, Jaideep S Bains.   

Abstract

Endocannabinoid signaling is distributed throughout the brain, regulating synaptic release of both excitatory and inhibitory neurotransmitters. The presence of endocannabinoid signaling within stress-sensitive nuclei of the hypothalamus, as well as upstream limbic structures such as the amygdala, suggests it may play an important role in regulating the neuroendocrine and behavioral effects of stress. The evidence reviewed here demonstrates that endocannabinoid signaling is involved in both activating and terminating the hypothalamic-pituitary-adrenal axis response to both acute and repeated stress. In addition to neuroendocrine function, however, endocannabinoid signaling is also recruited by stress and glucocorticoid hormones to modulate cognitive and emotional processes such as memory consolidation and extinction. Collectively, these data demonstrate the importance of endocannabinoid signaling at multiple levels as both a regulator and an effector of the stress response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21068301      PMCID: PMC3073528          DOI: 10.1523/JNEUROSCI.4283-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

Review 1.  1999 Curt P. Richter award. Glucocorticoids and the regulation of memory consolidation.

Authors:  B Roozendaal
Journal:  Psychoneuroendocrinology       Date:  2000-04       Impact factor: 4.905

Review 2.  Memory--a century of consolidation.

Authors:  J L McGaugh
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

3.  Endogenous cannabinoids trigger the depolarization-induced suppression of excitation in the lateral amygdala.

Authors:  Sodikdjon A Kodirov; Julia Jasiewicz; Parisa Amirmahani; Dimitrios Psyrakis; Kathrin Bonni; Michael Wehrmeister; Beat Lutz
Journal:  Learn Mem       Date:  2009-12-30       Impact factor: 2.460

4.  Endogenous cannabinoid signaling is essential for stress adaptation.

Authors:  Matthew N Hill; Ryan J McLaughlin; Brenda Bingham; Lalita Shrestha; Tiffany T Y Lee; J Megan Gray; Cecilia J Hillard; Boris B Gorzalka; Victor Viau
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 5.  Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.

Authors:  C J Hillard
Journal:  Prostaglandins Other Lipid Mediat       Date:  2000-04       Impact factor: 3.072

Review 6.  The endocannabinoid system and the treatment of mood and anxiety disorders.

Authors:  Matthew N Hill; Boris B Gorzalka
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

7.  Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala.

Authors:  Sachin Patel; Philip J Kingsley; Ken Mackie; Lawrence J Marnett; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2009-08-12       Impact factor: 7.853

8.  Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance.

Authors:  Eti Ganon-Elazar; Irit Akirav
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

Review 9.  Neural regulation of endocrine and autonomic stress responses.

Authors:  Yvonne M Ulrich-Lai; James P Herman
Journal:  Nat Rev Neurosci       Date:  2009-06       Impact factor: 34.870

10.  Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.

Authors:  Matthew N Hill; Ryan J McLaughlin; Anna C Morrish; Victor Viau; Stan B Floresco; Cecilia J Hillard; Boris B Gorzalka
Journal:  Neuropsychopharmacology       Date:  2009-08-26       Impact factor: 7.853

View more
  81 in total

1.  Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice.

Authors:  N P Bowles; M N Hill; S M Bhagat; I N Karatsoreos; C J Hillard; B S McEwen
Journal:  Neuroscience       Date:  2011-09-10       Impact factor: 3.590

2.  Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.

Authors:  R J Newsom; C Osterlund; C V Masini; H E Day; R L Spencer; S Campeau
Journal:  Neuroscience       Date:  2011-11-28       Impact factor: 3.590

3.  Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography.

Authors:  J Hirvonen; P Zanotti-Fregonara; J C Umhau; D T George; D Rallis-Frutos; C H Lyoo; C-T Li; C S Hines; H Sun; G E Terry; C Morse; S S Zoghbi; V W Pike; R B Innis; M Heilig
Journal:  Mol Psychiatry       Date:  2012-07-10       Impact factor: 15.992

4.  Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala.

Authors:  Florence P Varodayan; Michal Bajo; Neeraj Soni; George Luu; Samuel G Madamba; Paul Schweitzer; Marisa Roberto
Journal:  Addict Biol       Date:  2016-01-20       Impact factor: 4.280

5.  Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis.

Authors:  Christelle Glangetas; Delphine Girard; Laurent Groc; Giovanni Marsicano; Francis Chaouloff; François Georges
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

6.  Endocannabinoid signaling within the basolateral amygdala integrates multiple stress hormone effects on memory consolidation.

Authors:  Piray Atsak; Daniela Hauer; Patrizia Campolongo; Gustav Schelling; Raquel V Fornari; Benno Roozendaal
Journal:  Neuropsychopharmacology       Date:  2014-12-30       Impact factor: 7.853

Review 7.  Amygdala FAAH and anandamide: mediating protection and recovery from stress.

Authors:  Ozge Gunduz-Cinar; Matthew N Hill; Bruce S McEwen; Andrew Holmes
Journal:  Trends Pharmacol Sci       Date:  2013-10-25       Impact factor: 14.819

8.  Effects of oral Δ9-tetrahydrocannabinol on the cerebral processing of olfactory input in healthy non-addicted subjects.

Authors:  Carmen Walter; Bruno G Oertel; Lisa Felden; Ulrike Nöth; Johannes Vermehren; Ralf Deichmann; Jörn Lötsch
Journal:  Eur J Clin Pharmacol       Date:  2017-09-02       Impact factor: 2.953

9.  Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat.

Authors:  M D Lange; T Daldrup; F Remmers; H J Szkudlarek; J Lesting; S Guggenhuber; S Ruehle; K Jüngling; T Seidenbecher; B Lutz; H C Pape
Journal:  Mol Psychiatry       Date:  2016-10-04       Impact factor: 15.992

Review 10.  Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.

Authors:  Ryan Wyrofsky; Paul McGonigle; Elisabeth J Van Bockstaele
Journal:  Expert Opin Drug Discov       Date:  2014-12-09       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.